EFFECTS OF DIFFERENT DOSES OF ZINC PREPARATION ON GLYCEMIA AND ANTIOXIDANT PARAMETERS IN EXPERIMENTALLY INDUCED DIABETIC RABBITS

Z. Stanojević ,
Z. Stanojević

Institute of Pharmacology and Toxicology, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

R. Mitić ,
R. Mitić

Institute of Pharmacology and Toxicology, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

M. Stanić ,
M. Stanić

Biochemical-Clinical Laboratory, Health Center Kosovska Mitrovica , Kosovska Mitrovica , Kosovo*

M. Miletić ,
M. Miletić

Institute of Physiology, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

D. Valjarević ,
D. Valjarević

Department of mathematics, Faculty of Natural Sciences and mathematics Priština , Kosovska Mitrovica , Kosovo*

S. Hadžistević ,
S. Hadžistević

Institute of Pharmacology and Toxicology, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

M. Dejanović
M. Dejanović

Institute of Physiology, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

Published: 01.01.2011.

Volume 39, Issue 1 (2011)

pp. 27-31;

https://doi.org/10.70949/pramed201101392S

Abstract

Researches with micronutrients are getting more and more important in science and also in practice. In this view zinc, chromium, copper and selenium are having a special role in preventing micro- and macrovascular diabetic complications, as integral components of antioxidant enzymes (superoxide dismutase and glutathione peroxidase) and also as cofactor of enzymes and hormones involved in the metabolism of glucose and lipid. The aim of this study was to evaluate the effects different doses of zinc on glycemia and parameters of antioxidative defense: superoxide dismutase (SOD) and total antioxidant status (TAS), and correlation glycoregulation with antioxidant system of the alloxan-induced diabetic rabbits. The study was conducted on fourteen New Zealand rabbits of both sexes, weighing 2 to 3.5 kg. Experimental diabetes was induced in rabbits by intravenous injection of alloxan (80 mg /kg BW). Three weeks after induced experimental diabetes, rabbits were treated orally appropriate doses of chelated zinc: I dose - 15 mg, after a washout period (10 t ), II dose - 25 mg, af- 1/2 ter a washout period, III dose - 50 mg. Blood samples were taken at specific time intervals: before alloxan induced diabetes, after alloxan induced diabetes, after application the first dose of 15 mg of zinc, after application of a second dose of 25 mg of zinc, after application of third dose of 50 mg of zinc. The zinc preparation did not cause a statistically significant reduction in serum glucose level when administered in single doses 15, 25 and 50 mg in experimentally induced diabetic rabbits. However, the activity of superoxide dismutase (SOD) was significantly increased after single dose preparations of zinc at a dose 15 mg (p<0,05), 25 mg (p<0,001) and 50 mg (p<0,001) in relation to the activity recorded before the application of zinc. Also, after the application first, second, and than third dose of zinc in diabetic rabbits was recorded statistically significant increase of TAS in relation to the value recorded before the application of zinc (p<0,001). Glucose concentrations negatively correlated with superoxide dismutase activity. This indicates that oral application of zinc preparation can reduce the harmful effects of oxidative stress in diabetes.

Keywords

References

1.
Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Science MAC. 84:407–12.
2.
Duzguner V, Kaya S. Effect of zinc on the lipid peroxidation and the antioxidant defense system of the alloxan-induced diabetic rabbits. Free Radic Biol Med. 42:1481–6.
3.
Đukić M. Oksidativni stres – slobodni radikali, prooksidansi i antioksidansi. Farmaceutski fakultet Univerziteta u Beogradu.
4.
Yoshikawa Y, Ueda E, Kojima Y, Sakurai H. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes. Life Sci. 75:741–51.
5.
Tallman DL, Taylor CG. Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2. Can J Physiol Pharmacol. 77(12):912–33.
6.
Chen MD, Song YM, Lin PY. Zinc effects on hyperglycemia and hypoleptinemia in streptozotocin-induced diabetic mice. Horm Metab Res. 32(3):107–9.
7.
Simon SF, Taylor CG. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med (Maywood. 226(1):43–51.
8.
Chen MD, Lion SJ, Lin PY, Yang VC, Alexander PC, Lin WH. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese mice. Biol Trace Elem Res. 61(3):303–11.
9.
Goldstein S, Michel C, Boors A, Saran M, Czapsky G. A critical re-evaluation of some assay methods for superoxide dismutase activity. Free Radic Biol Med. 4:295–303.
10.
Thompson KH, Godin DV. Micronutrients and antioxidants in the progression of diabetes mellitus. Nutr Res. 15(9):1377–410.
11.
Burin JM, Price CP. Measurement of blood glucose. Ann Clin Biochem. 22:327–42.
12.
Brandão-Neto J, Silva C, Shuhama T, Silva J, Oba L. Renal handling of zinc in insulin-dependent diabetes mellitus patients. BioMetals. 14:75–80.
13.
Kaji M. Zinc in Endocrinology. Int Pediatr. 16(3):1–7.
14.
Brandão-Neto J, Silva C, Rezende A, Almeida M, Sales V, Marchini J. Zinc pharmacokinetics in insulin-dependent diabetes mellitus patients after oral zinc tolerance test. Nutr Res. 23:141–50.
15.
Rosenthal MJ, Hwang IK. Effects of arachidonic acid and cyclo (his-pro) on zinc transport across small intestine and muscle tissues. Life Sci. 70:337–48.
16.
Tasić NM, Radak D, Cvetković Z, Marijan M, Tasić D, Radak S, et al. Cink i ateroskleroza karotidnog plaka. Scr Med. 1(1).
17.
Domitrović R, Mililć E. Biokemija cinka. Biochem Med. 10(1–2):21–7.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by